Focus Financial Network’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Hold
1,087
0.01% 713
2026
Q1
$204K Hold
1,087
0.01% 701
2025
Q4
$206K Buy
+1,087
New +$201K 0.01% 703
2024
Q1
Sell
-14,083
Closed -$2.33M 637
2023
Q4
$2.33M Buy
+14,083
New +$2.17M 0.09% 190
2022
Q2
Sell
-1,893
Closed -$307K 482
2022
Q1
$307K Sell
1,893
-13,283
-88% -$2.15M 0.02% 397
2021
Q4
$2.87M Sell
15,176
-120
-0.8% -$23.1K 0.42% 58
2021
Q3
$3.09M Sell
15,296
-154
-1% -$32.3K 0.41% 58
2021
Q2
$3.12M Sell
15,450
-357
-2% -$66.5K 0.41% 62
2021
Q1
$2.77M Buy
15,807
+13,923
+739% +$2.52M 0.32% 72
2020
Q4
$320K Buy
1,884
+4
+0.2% +$659 0.03% 339
2020
Q3
$305K Buy
1,880
+120
+7% +$19.5K 0.03% 334
2020
Q2
$287K Hold
1,760
0.03% 305
2020
Q1
$225K Sell
1,760
-475
-21% -$64K 0.03% 321
2019
Q4
$312K Buy
2,235
+4
+0.2% +$526 0.04% 309
2019
Q3
$263K Sell
2,231
-67
-3% -$8.33K 0.04% 316
2019
Q2
$296K Hold
2,298
0.04% 292
2019
Q1
$295K Buy
+2,298
New +$290K 0.05% 284

Other funds holding BBH

Focus Financial Network's BBH Position: Q2 2026 in Review

Focus Financial Network held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 1,087 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #713.

Focus Financial Network first reported a position in BBH in Q1 2019 and has held it in 17 quarters since. The position peaked at $3.12M in Q2 2021. 20 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • Focus Financial Network held 1,087 shares of VanEck Biotech ETF worth $221K as of Q2 2026.
  • Focus Financial Network left its VanEck Biotech ETF share count unchanged in Q2 2026.
  • VanEck Biotech ETF made up 0.01% of Focus Financial Network's portfolio in Q2 2026, its #713 holding.
  • Focus Financial Network first reported a position in VanEck Biotech ETF in Q1 2019 and has held it in 17 quarters since.
  • Focus Financial Network's VanEck Biotech ETF position peaked at $3.12M in Q2 2021.
  • 20 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Focus Financial Network's 13F filing for Q2 2026, filed 9 Jul 2026.